http://orcid.org/0000-0003-0709-8832
References
- Farashi S, Vakili S, Garous NF, et al. Identification of mutations causing aberrant termination and deficient splice donor site on the HBA1 gene. Hemoglobin. 2016;40(1):38–43.
- Farashi S, Rad F, Shahmohammadi B, et al. First Report of a dominantly inherited β-thalassemia caused by a novel elongated β-globin chain. Hemoglobin. 2016;40(2):102–107.
- Rezaee AR, Banoei MM, Khalili E, et al. β-Thalassemia in Iran: new insight into the role of genetic admixture and migration. ScientificWorldJournal. 2012;2012:1–7.
- Jaripour ME, Hayatigolkhatmi K, Iranmanesh V, et al. Prevalence of β-thalassemia mutations among Northeastern Iranian population and their impacts on hematological indices and application of prenatal diagnosis, a seven-years study. Mediterr J Hematol Infect Dis. 2018;10(1):e2018042.
- Rahimi Z, Raygani AV, Merat A, et al. Thalassemic mutations in southern Iran. Iranian J Med Sci. 2015;31(2):70–73.
- Khodaei GH, Farbod N, Zarif B, et al. Frequency of thalassemia in Iran and Khorasan Razavi. Int J Pediatr. 2013;1(1):45–50.
- Ebrahimi M, Mohammadi-Asl J, Rahim F. Molecular spectrum and distribution of hemoglobinopathies in southwest of Iran: a seven-year retrospective study. J Hematopathol. 2020. DOI:10.1007/s12308-020-00388-7
- Moosavi A, Ardekani AM. The frequency and importance of common α-globin gene deletions among β-thalassemia carriers in an Iranian population. Avicenna J Med Biotechnol. 2017;9(4):196–200.
- McPherson RA, Pincus MR, editors. Henry’s clinical diagnosis and management by laboratory methods. 22nd ed. (E-Book). India: Elsevier Health Sciences; 2017.
- Ayatollahi M, Zakerinia M, Haghshenas M. Molecular analysis of Iranian families with sickle cell disease. J Trop Pediatr. 2005;51(3):136–140.
- Figueiredo MS. The compound state: Hb S/β-thalassemia. Rev Bras Hematol Hemoter. 2015;37(3):150–152.
- Benites BD, Bastos SO, Baldanzi G, et al. Sickle cell/β-thalassemia: comparison of Sβ0 and Sβ+ Brazilian patients followed at a single institution. Hematology. 2016;21(10):623–629.
- Ataga KI, Cappellini MD, Rachmilewitz EA. β Thalassaemia and sickle cell anaemia as paradigms of hypercoagulability. Br J Haematol. 2007;139(1):3–13.
- Saleh-Gohari N, Mohammadi-Anaie M. Co-inheritance of sickle cell trait and thalassemia mutations in South Central Iran. Iranian J Public Health. 2012;41(10):81–86.
- HbVar database. [cited 2020 Mar 10]. Available from: http://globin.cse.psu.edu/hbvar/
- Çürük MA, Zeren F, Genç A, et al. Prenatal diagnosis of sickle cell anemia and β-thalassemia in southern Turkey. Hemoglobin. 2008;32(6):525–530.
- Mukherjee MB, Nadkarni AH, Gorakshakar AC, et al. Clinical, hematologic and molecular variability of sickle cell-β thalassemia in western India. Indian J Hum Genet. 2010;16(3):154–158.
- Nadkarni A, Gorakshakar A, Lu C, et al. Molecular pathogenesis and clinical variability of β thalassemia syndromes among Indians. Am J Hematol. 2001;68(2):75–80.
- Baysal E, Huisman T. Detection of common deletional α-thalassemia-2 determinants by PCR. Am J Hematol. 1994;46(3):208–213.
- El-Hazmi MA, Al-Hazmi AM, Warsy AS. Sickle cell disease in Middle East Arab countries. Indian J Med Res. 2011;134(5):597–610.
- Payandeh M, Rahimi Z, Zare ME, et al. The prevalence of anemia and hemoglobinopathies in the hematologic clinics of the Kermanshah Province, Western Iran. Int J Hematol Oncol Stem Cell Res. 2014;8(2):33–37.
- Najmabadi H, Karimi-Nejad R, Sahebjam S, et al. The β-thalassemia mutation spectrum in the Iranian population. Hemoglobin. 2001;25(3):285–296.
- Guvenc B, Canataroglu A, Unsal C, et al. β-Globin chain abnormalities with coexisting α-thalassemia mutations. Arch Med Sci. 2012;4(4):644–649.
- Sankar VH, Arya V, Tewari D, et al. Genotyping of α-thalassemia in microcytic hypochromic anemia patients from North India. J Appl Genet. 2006;47(4):391–395.
- Nava MP, Ibarra B, Magaña MT, et al. Prevalence of –α3.7 and ααα anti 3.7 alleles in sickle cell trait and β-thalassemia patients in Mexico. Blood Cells Mol Dis. 2006;36(2):255–258.